Hikma expands into Canada with acquisition of Teligent Inc
LONDON, UK: Hikma Pharmaceuticals, the multinational pharmaceutical company, has agreed to acquire the Canadian assets of Teligent Inc. for $45.75 million. The transaction is expected to be completed before the end of the first quarter of 2022. The acquisition marks Hikma’s expansion into Canada and includes a portfolio of 25 sterile injectable products, three in-licenced…